In the absence of large-scale data other than those derived from case reports or adverse drug reports, we sought to investigate the prevalence, clinical features and treatment of G-CSF-induced acute aortitis in patients treated with adjuvant or neoadjuvant chemotherapy and PEGylated filgrastim for breast cancer. This evidence concerns the gene CSF3 and breast cancer.